1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23840
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSrinivasan, Ashish-
dc.contributor.authorDe Cruz, Peter P-
dc.contributor.authorvan Langenberg, Daniel R-
dc.date.accessioned2020-07-16T03:31:44Z-
dc.date.available2020-07-16T03:31:44Z-
dc.date.issued2020-08-
dc.identifier.citationAlimentary Pharmacology & Therapeutics 2020; 52(3): 561-562en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/23840-
dc.language.isoeng-
dc.titleLetter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail.en
dc.typeJournal Articleen
dc.identifier.journaltitleAlimentary Pharmacology & Therapeuticsen
dc.identifier.affiliationDepartment of Gastroenterology, Eastern Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationGastroenterology and Hepatologyen
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.affiliationDepartment of Medicine, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1111/apt.15862en
dc.type.contentTexten
dc.identifier.orcid0000-0001-5952-1570en
dc.identifier.orcid0000-0003-3662-6307en
dc.identifier.pubmedid32656826-
dc.type.austinLetter-
local.name.researcherDe Cruz, Peter P
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

58
checked on Apr 18, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.